Marin General Hospital Continues Popular Free Prostate Cancer Screening

Marin General Hospital Continues Popular Free Prostate Cancer Screening

GREENBRAE, CA — Marin General Hospital will once again offer its popular free, two-part prostate cancer screening, aimed at early detection for North Bay residents. This year, PSA blood draws will take place September 4-14, followed by the Digital Rectal Exam (DRE) on September 22, 2012, 9 am to 12 pm at the Marin Cancer Institute. Both parts of the screening must be completed and registration is required (1-888-99-MY-MGH).

The initial screening, a PSA blood draw, offered 9/4-9/14 to registered participants at Marin General Hospital Outpatient Laboratories, 250 Bon Air Road, 2nd Floor, in Greenbrae. No appointment is necessary.

The second part of the screening is a follow-up exam Saturday, Sept. 22, 9 am to 12 pm, at the Marin Cancer Institute (MCI), 1350 S. Eliseo Dr., Greenbrae, CA.

"We particularly want to emphasize this year that no one should be discouraged from having PSA screening for prostate cancer," says Dr. Gary Grossfeld, MD, FACS, a fellowship-trained urologist, specializing in oncology, at Marin General Hospital. "Prostate cancer is the second leading cause of cancer death in U.S. men, who have a 16% lifetime risk of being diagnosed with it. Since the introduction of routine PSA screening there has been a 30% reduction in prostate cancer mortality and a 75% drop in the most advanced (metastatic) cancers, which are the hardest to treat and cause the most suffering. While a high PSA reading doesn't always lead to a biopsy or treatment, PSA testing is an invaluable tool as part of a comprehensive assessment of prostate health."

The Marin Cancer Institute is a leader in prostate cancer diagnosis and treatment, providing comprehensive, highly specialized care from a collaborative team of university-caliber surgeons, oncologists, and other prostate cancer specialists using the latest technology to deliver advanced surgical and radiation therapy through the Marin Cancer Institute. MCI also offers access to clinical trials, providing patients options for leading-edge treatments. The hospital's prostate cancer survival rates are consistently above the national average.

Physicians participating in this year's free screening include Patrick Bennett, MD; Gary Grossfeld, MD; Alex Metzger, MD; Lloyd Miyawaki, MD; Joe Poen, MD. For more information or to register, call 1-888-99-MY-MGH (1-888-996-9644).